Human papillomavirus vaccine: progress and the future.
A vaccine to prevent infection by human papillomavirus is available in the US. This article reviews the biology of human papillomavirus that allows for the development of both therapeutic and prophylactic vaccines. Issues that may delay the acceptance of the vaccine are discussed.
Dinh
Tri A
TA
The Methodist Hospital, Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, 6550 Fannin, Suite 901, Houston, TX 77030, USA. tadinh@tmh.tmc.edu
Benoit
Michelle F
MF
D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D005544:Forecasting; D006801:Humans; D015994:Incidence; D027383:Papillomaviridae / Q000145:classification / Q000235:genetics / Q000472:pathogenicity*; D053918:Papillomavirus Vaccines / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000517:prevention & control* / Q000821:virology
D053918:Papillomavirus Vaccines